CA2822746A1 - Compositions et methodes de traitement du vitiligo - Google Patents

Compositions et methodes de traitement du vitiligo Download PDF

Info

Publication number
CA2822746A1
CA2822746A1 CA2822746A CA2822746A CA2822746A1 CA 2822746 A1 CA2822746 A1 CA 2822746A1 CA 2822746 A CA2822746 A CA 2822746A CA 2822746 A CA2822746 A CA 2822746A CA 2822746 A1 CA2822746 A1 CA 2822746A1
Authority
CA
Canada
Prior art keywords
composition
skin
rapamycin
effective amount
cosmeceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2822746A
Other languages
English (en)
Inventor
Sarah Bacus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
0901911 BC UNLIMITED LIABILITY Co
Original Assignee
Sarah Bacus
Biocosmeceuticals, LLC
0901911 B.C. Unlimited Liability Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarah Bacus, Biocosmeceuticals, LLC, 0901911 B.C. Unlimited Liability Company filed Critical Sarah Bacus
Publication of CA2822746A1 publication Critical patent/CA2822746A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01009—Glutathione peroxidase (1.11.1.9)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CA2822746A 2009-12-21 2010-12-21 Compositions et methodes de traitement du vitiligo Abandoned CA2822746A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28868809P 2009-12-21 2009-12-21
US61/288,688 2009-12-21
US31567210P 2010-03-19 2010-03-19
US61/315,672 2010-03-19
PCT/US2010/061661 WO2011079154A1 (fr) 2009-12-21 2010-12-21 Compositions et méthodes de traitement du vitiligo

Publications (1)

Publication Number Publication Date
CA2822746A1 true CA2822746A1 (fr) 2011-06-30

Family

ID=44196131

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2822746A Abandoned CA2822746A1 (fr) 2009-12-21 2010-12-21 Compositions et methodes de traitement du vitiligo

Country Status (3)

Country Link
EP (1) EP2515652A4 (fr)
CA (1) CA2822746A1 (fr)
WO (1) WO2011079154A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2671583A4 (fr) * 2011-01-31 2014-09-03 Univ Osaka Médicament à usage externe pour traiter un trouble cutané et procédé pour produire celui-ci
CN102552253A (zh) * 2012-01-17 2012-07-11 唯美度科技（北京）有限公司 一种祛痘用皮肤外用剂
CN104324367A (zh) * 2014-10-20 2015-02-04 广西壮族自治区花红药业股份有限公司 鱼鳞提取物在制备治疗和/或预防白癜风药物方面的新用途
JP2018528236A (ja) 2015-09-24 2018-09-27 ドレクセル ユニバーシティ 真皮障害を治療または予防するための新規組成物および方法
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362735A (en) * 1994-02-23 1994-11-08 Smithkline Beecham Corporation Rapamycin derivatives
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6936426B2 (en) * 2000-10-06 2005-08-30 Harbor-Ucla Research And Education Institute Detection of antibody mediated inflammatory auto-immune disorders
EP1230917A1 (fr) * 2001-02-08 2002-08-14 Vectron Therapeutics AG Invasomes pour la thérapie des maladies, leurs fabrication et utilisation
US20070026042A1 (en) * 2005-07-29 2007-02-01 Narayanan Pallasssana V System for treating aneurysmal disease
SI2957292T1 (en) * 2008-03-27 2018-04-30 Clinuvel Pharmaceuticals Limited Vitiligo therapy

Also Published As

Publication number Publication date
EP2515652A4 (fr) 2014-11-26
EP2515652A1 (fr) 2012-10-31
WO2011079154A1 (fr) 2011-06-30

Similar Documents

Publication Publication Date Title
US8946256B2 (en) Compositions and methods for treatment of vitiligo
CA2907495C (fr) Compositions d'antioxydants et procedes d'utilisation
JP4234137B2 (ja) ヘキサミジン組成物を用いた哺乳類のケラチン組織の調整
ES2259034T3 (es) Uso de un enantiomero del acido lipoico en cosmeticos y dermatologicos.
US9387160B2 (en) Composition and method of treating skin conditions
US20070042026A1 (en) Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO1998053822A1 (fr) Pyridine-thiols inversant le vieillissement cutaneo-muqueux
JP2005503335A (ja) 糖アミンを含有するスキンケア組成物
JP2003530302A (ja) 皮膚ケア活性剤を組み合わせて含有する皮膚ケア組成物
US6267971B1 (en) Use of cinnamic acid or of its derivatives in a cosmetic firming composition
JP2009508895A (ja) オピオイド受容体拮抗薬の使用
US20110150798A1 (en) Compositions and methods for increasing cellular far and bleaching skin
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
CA2822746A1 (fr) Compositions et methodes de traitement du vitiligo
US20110250157A1 (en) Skin Hyperpigmentation Acyl Glutathione Treatments
US20030068349A1 (en) Use of 5'-deoxy-5'-methylthioadenosine in skin cosmetic compositions
US20150202187A1 (en) Compositions and methods for treatment of vitiligo
JP2004512295A (ja) 皮膚加齢の徴候を処置するための少なくとも１種のカロチノイドと少なくとも１種のイソフラボノイドの組合せ物の使用
JP2004512294A (ja) 加齢の徴候を処置するためのプロビタミンａ活性を有する少なくとも１種のカロチノイドとプロビタミンａ活性を有さない少なくとも１種のカロチノイドの組合せ物の使用
KR20170066419A (ko) 10-하이드록시스테아르산을 포함하는 화장품 조성물의 용도
EP2133066A1 (fr) Composition cosmétique et dermatologique contenant un mélange de dérivés de rétinol et des tocotriénols.
JP2002544218A (ja) 哺乳動物のケラチン組織状態を調整する方法
KR101582652B1 (ko) 주름개선용 화장료 조성물
EP2515830A1 (fr) Compositions et méthodes pour l'augmentation de la graisse cellulaire et le blanchiment de la peau
WO2012084309A2 (fr) Composition éclaircissant la peau

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151221

FZDE Dead

Effective date: 20180807